Merck And River Blindness Case Study

Register to read the introduction… How do you think Merck’s Investments in the human version of Ivermectin created value for its stakeholders and corporate goodwill?
Upon learning about victims suffering from river blindness, Merck realized that they had a potential cure to the problem. With this knowledge Merck had a corporate social responsibility to develop a drug because they now had an obligation to take action that could possibly contribute to the welfare and interests of society, as well as the organization and its stakeholders.
Each stakeholder (which is any person who has a direct or indirect relationship with the organization) could feel and see the value that this project could provide. As people invest time and money into an organization they want to experience a return of their investment. One of the greatest returns a person can experience is seeing someone’s life change for the better. This investment of each stakeholder’s time and money in a human version of Ivermectin would create a high level of value for the entire organization and the corporate